Prurigo Nodularis

Tips and Tricks for Diagnosing & Managing Atopic Dermatitis (AD)
atopic dermatitis
by Edita Newton, MD on
Atopic dermatitis is a heterogeneous, chronic inflammatory disease that affects upwards of 10% of children and 7% of adults in the United States. Despite being an incredibly common skin concern among patients, AD continues to pose diagnostic and treatment challenges to dermatologists. What are some common misconceptions about AD? AD always starts in childhood. FALSE. 25% of adults w …
Thalidomide for Dermatologic Conditions | Therapeutic Cheat Sheet
Thalidomide
by Emily Murphy, MD on
Thalidomide was introduced in the 1950s as a “safe” sleeping medication; however, it quickly became vilified and was removed from the market for its severe teratogenic effects, most commonly phecomelia, or loss of arms and legs. Despite these devastating birth defects, thalidomide has a variety of indications for dermatologic conditions, with manageable side effects when used appropriately. We …
Pregabalin for Chronic Pruritus | Therapeutic Cheat Sheet
by Azam Qureshi, MD on
Chronic pruritus affects 8-16% of the general population and has a profound impact on patient quality of life.1-3Although the symptom of pruritus may originate from a number of underlying etiologies, including metabolic derangements and infectious causes, along with neoplastic, inflammatory, or psychiatric conditions, other cases may be idiopathic in nature.4 Given the diversity of underlying cont …
Gabapentin for Itch – Therapeutic Cheat Sheet
Gabapentin for itch
by Blair Allais, MD on
Gabapentin is a well-established treatment option for itch with a reassuring safety profile that does not require continued lab monitoring. Generalized itching is a common cause of visits to the dermatologist and can be difficult to treat, leading to sleepless nights and inability to function. We continue our series, Therapeutic Cheat Sheet, with a closer look at gabapentin. GABAPENTIN THERAPEUT …
Dupilumab Therapeutic Cheat Sheet
Dupilumab
by Azam Qureshi, MD on
Atopic dermatitis (AD) is a common skin condition characterized by pruritus and occurs as a result of factors related to impaired skin barrier and immune response, as well as environmental and infectious agents. Patients with poor control on topical therapy are looking for safe and effective systemic treatments. We continue our series, Therapeutic Cheat Sheet, with a closer look at dupilumab, whic …